Page last updated: 2024-08-16

timolol and bucindolol

timolol has been researched along with bucindolol in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chandrasena, G; Gavai, AV; Nayeem, A; Santone, K; Vaz, RJ	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1

Other Studies

2 other study(ies) available for timolol and bucindolol

Article	Year
A 3D-QSAR model for CYP2D6 inhibition in the aryloxypropanolamine series. Bioorganic & medicinal chemistry letters, 2005, Sep-01, Volume: 15, Issue:17 Topics: Animals; Cytochrome P-450 CYP2D6 Inhibitors; Humans; Inhibitory Concentration 50; Models, Molecular; Propanolamines; Quantitative Structure-Activity Relationship; Substrate Specificity	2005
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008

Article

Year

A 3D-QSAR model for CYP2D6 inhibition in the aryloxypropanolamine series.

Bioorganic & medicinal chemistry letters, 2005, Sep-01, Volume: 15, Issue:17

Topics: Animals; Cytochrome P-450 CYP2D6 Inhibitors; Humans; Inhibitory Concentration 50; Models, Molecular; Propanolamines; Quantitative Structure-Activity Relationship; Substrate Specificity

2005

Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.

Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008